Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

PHA Response

Immunology & Autoimmune

Lymphocyte transformation test (PHA)PHA LTTT-cell mitogen response (PHA)

Review status

Currently under review

Pending specialist review and validation.

What it shows

The PHA response test evaluates how your T lymphocytes function by measuring their activation and proliferation when exposed to phytohemagglutinin, a plant lectin that serves as a strong mitogen. In the laboratory, your white blood cells are incubated with this stimulus and the response is quantified, often as the proportion of cells that activate or a calculated index.

This is a functional assay of cellular immunity that complements routine cell counts. It helps show whether your T cells can mount a generalized response to a nonspecific trigger under controlled conditions.

Why it matters

Clinicians order this test when there are concerns about cellular immune deficiency, such as frequent, severe, or unusual infections, or to monitor the effects of medicines that suppress the immune system. It can also be used after transplantation or during evaluation of systemic illnesses that may lower T-cell function.

Results help determine if further immune evaluation is needed and whether changes in treatment or timing of procedures are appropriate. A reduced response may reflect medication effects, active viral infection, malnutrition, or an underlying immune disorder, while a preserved response supports adequate T-cell function at the time of testing.

Understanding your results

If your result falls within the laboratory’s expected range, it suggests your T cells are viable and capable of responding to a strong, nonspecific signal in vitro. A lower than expected response can occur if the sample was delayed, if lymphocytes were stressed, or if your immune system is suppressed or temporarily affected by illness.

Your clinician will interpret this result together with your symptoms, lymphocyte subset counts, immunoglobulin levels, and responses to other stimuli. If the result is unexpected, the test may be repeated on a freshly collected sample or after reviewing medication timing, and additional targeted tests may be recommended. Do not adjust any medicines without medical advice.

Reference ranges

3555 %
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact PHA Response

  • Immunosuppressive medications

    Corticosteroids, calcineurin inhibitors, mTOR inhibitors, chemotherapy, and many biologics can blunt T-cell responses to mitogens like PHA.

  • Recent infection or vaccination

    Acute viral illness or recent vaccination can temporarily lower or alter T-cell responsiveness, leading to transiently low results.

  • Specimen handling and timing

    Delayed processing, incorrect anticoagulant, or temperature extremes reduce lymphocyte viability and can artifactually lower the response.

  • Age and nutritional status

    Very young or older age, malnutrition, or micronutrient deficiencies can influence T-cell function and change test performance.

  • Pregnancy

    Physiologic immune modulation during pregnancy can dampen mitogen responses and may modestly lower measured reactivity.

  • Chronic viral infections

    Infections that target immune cells, such as HIV, can impair T-cell function and reduce responses to PHA stimulation.

  • Autoimmune or inflammatory conditions

    Active autoimmune disease or chronic inflammation can shift immune cell activation patterns and affect mitogen responses.

2026

References

  1. McGill University Health Centre. (2021, June 07). PHA Response (Task CD 23030932). Laboratory reference ranges.
  2. Bonilla, F. A., Khan, D. A., Ballas, Z. K., Chinen, J., Frank, M. M., Hsu, J. T., Keller, M., Kobrynski, L., Komarow, H. D., Malech, H. L., Nelson, R. P., Orange, J. S., Routes, J. M., Shearer, W. T., Sorensen, R. U., & Sullivan, K. (2015). Practice parameter for the diagnosis and management of primary immunodeficiency. Journal of Allergy and Clinical Immunology, 136(5), 1186-1205.e78.